Omeros (OMER) Income from Continuing Operations (2010 - 2026)

Omeros' (OMER) quarterly Income from Continuing Operations came in at 51249000.0 in Q1 2026, up 236.43% year-on-year from 15233295.76 in Q1 2025, and up 239.68% quarter-over-quarter from 36690000.0 in Q4 2025.

Omeros (OMER) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Omeros has disclosed Income from Continuing Operations across 17 years of filings, most recently posting 51249000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 51249000.0, up 236.43% year-over-year; the trailing twelve-month figure through Mar 2026 was 28990000.0 (up 83.34% YoY), and the FY2025 annual result was 4808000.0, up 97.37% from the prior year.
  • Income from Continuing Operations came in at 51249000.0 for Q1 2026 at Omeros, up from 36690000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 51249000.0 in Q1 2026 to a low of 65125000.0 in Q2 2024.
  • The 5-year median for Income from Continuing Operations is 39683000.0 (2023), against an average of 35762294.12.
  • Across the five-year window, Income from Continuing Operations tumbled 141.34% in 2022 and jumped 236.43% in 2026, its largest moves.
  • Omeros' Income from Continuing Operations stood at 46048000.0 in 2022, then grew by 5.75% to 43399000.0 in 2023, then climbed by 21.07% to 34255000.0 in 2024, then fell by 7.11% to 36690000.0 in 2025, then jumped by 239.68% to 51249000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 51249000.0 (Q1 2026), 36690000.0 (Q4 2025), and 12421000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn 51.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.25 Mn
Dec 31, 2025 -36.69 Mn
Sep 30, 2025 -12.42 Mn
Jun 30, 2025 -31.13 Mn
Mar 31, 2025 -37.57 Mn
Dec 31, 2024 -34.26 Mn
Sep 30, 2024 -37.11 Mn
Jun 30, 2024 -65.13 Mn
Mar 31, 2024 -43.85 Mn
Dec 31, 2023 -43.40 Mn
Sep 30, 2023 -51.66 Mn
Jun 30, 2023 -44.29 Mn
Mar 31, 2023 -39.68 Mn
Dec 31, 2022 -46.05 Mn
Sep 30, 2022 -54.79 Mn
Jun 30, 2022 -41.70 Mn
Mar 31, 2022 -39.49 Mn
Dec 31, 2021 -105.16 Mn
Sep 30, 2021 -22.70 Mn
Jun 30, 2021 -50.52 Mn